0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Research Report 2023
Published Date: May 2023
|
Report Code: QYRE-Auto-16Y7905
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Bruton s Tyrosine Kinase BTK Inhibitor Market Insights and Forecast to 2028
BUY CHAPTERS

Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Research Report 2023

Code: QYRE-Auto-16Y7905
Report
May 2023
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bruton’s Tyrosine Kinase (BTK) Inhibitor Market

The global Bruton’s Tyrosine Kinase (BTK) Inhibitor market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Bruton’s Tyrosine Kinase (BTK) Inhibitor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Bruton’s Tyrosine Kinase (BTK) Inhibitor is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Bruton’s Tyrosine Kinase (BTK) Inhibitor include AbbVie, Johnson & Johnson, Principia Biopharma, Merck, Sunesis Pharmaceuticals, BeiGene, Novartis, Sanofi and Celgene Corporation, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bruton’s Tyrosine Kinase (BTK) Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bruton’s Tyrosine Kinase (BTK) Inhibitor.
The Bruton’s Tyrosine Kinase (BTK) Inhibitor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bruton’s Tyrosine Kinase (BTK) Inhibitor market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bruton’s Tyrosine Kinase (BTK) Inhibitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Scope of Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Report

Report Metric Details
Report Name Bruton’s Tyrosine Kinase (BTK) Inhibitor Market
Segment by Type
  • Acalabrutinib
  • Zanubrutinib
  • Ibrutinib
Segment by Application
  • Tumor
  • Autoimmunity
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, Johnson & Johnson, Principia Biopharma, Merck, Sunesis Pharmaceuticals, BeiGene, Novartis, Sanofi, Celgene Corporation, Loxo, ArQule, Hengrui
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Bruton’s Tyrosine Kinase (BTK) Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Bruton’s Tyrosine Kinase (BTK) Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.
1 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Overview
1.1 Product Overview and Scope of Bruton’s Tyrosine Kinase (BTK) Inhibitor
1.2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Segment by Type
1.2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Value Comparison by Type (2023-2029)
1.2.2 Acalabrutinib
1.2.3 Zanubrutinib
1.2.4 Ibrutinib
1.3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Segment by Application
1.3.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Value by Application: (2023-2029)
1.3.2 Tumor
1.3.3 Autoimmunity
1.4 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size Estimates and Forecasts
1.4.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue 2018-2029
1.4.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales 2018-2029
1.4.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Competition by Manufacturers
2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Manufacturers (2018-2023)
2.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Average Price by Manufacturers (2018-2023)
2.4 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Product Type & Application
2.7 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Competitive Situation and Trends
2.7.1 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bruton’s Tyrosine Kinase (BTK) Inhibitor Players Market Share by Revenue
2.7.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Retrospective Market Scenario by Region
3.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region: 2018-2029
3.2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region: 2018-2023
3.2.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region: 2024-2029
3.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region: 2018-2029
3.3.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region: 2018-2023
3.3.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region: 2024-2029
3.4 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Facts & Figures by Country
3.4.1 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2018-2029)
3.4.3 North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Facts & Figures by Country
3.5.1 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2018-2029)
3.5.3 Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Facts & Figures by Country
3.6.1 Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2018-2029)
3.6.3 Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Facts & Figures by Country
3.7.1 Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2018-2029)
3.7.3 Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Facts & Figures by Country
3.8.1 Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2018-2029)
3.8.3 Middle East and Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2018-2029)
4.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2018-2023)
4.1.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Type (2024-2029)
4.1.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2018-2029)
4.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Type (2018-2029)
4.2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Type (2018-2023)
4.2.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Type (2024-2029)
4.2.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Type (2018-2029)
4.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Type (2018-2029)
5 Segment by Application
5.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2018-2029)
5.1.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2018-2023)
5.1.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Application (2024-2029)
5.1.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2018-2029)
5.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Application (2018-2029)
5.2.1 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Application (2018-2023)
5.2.2 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Application (2024-2029)
5.2.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Application (2018-2029)
5.3 Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Principia Biopharma
6.3.1 Principia Biopharma Corporation Information
6.3.2 Principia Biopharma Description and Business Overview
6.3.3 Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio
6.3.5 Principia Biopharma Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Sunesis Pharmaceuticals
6.5.1 Sunesis Pharmaceuticals Corporation Information
6.5.2 Sunesis Pharmaceuticals Description and Business Overview
6.5.3 Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio
6.5.5 Sunesis Pharmaceuticals Recent Developments/Updates
6.6 BeiGene
6.6.1 BeiGene Corporation Information
6.6.2 BeiGene Description and Business Overview
6.6.3 BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.6.4 BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio
6.6.5 BeiGene Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Celgene Corporation
6.9.1 Celgene Corporation Corporation Information
6.9.2 Celgene Corporation Description and Business Overview
6.9.3 Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio
6.9.5 Celgene Corporation Recent Developments/Updates
6.10 Loxo
6.10.1 Loxo Corporation Information
6.10.2 Loxo Description and Business Overview
6.10.3 Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio
6.10.5 Loxo Recent Developments/Updates
6.11 ArQule
6.11.1 ArQule Corporation Information
6.11.2 ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Description and Business Overview
6.11.3 ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.11.4 ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio
6.11.5 ArQule Recent Developments/Updates
6.12 Hengrui
6.12.1 Hengrui Corporation Information
6.12.2 Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Description and Business Overview
6.12.3 Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Product Portfolio
6.12.5 Hengrui Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bruton’s Tyrosine Kinase (BTK) Inhibitor Industry Chain Analysis
7.2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Production Mode & Process
7.4 Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales and Marketing
7.4.1 Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Channels
7.4.2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Distributors
7.5 Bruton’s Tyrosine Kinase (BTK) Inhibitor Customers
8 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Dynamics
8.1 Bruton’s Tyrosine Kinase (BTK) Inhibitor Industry Trends
8.2 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Drivers
8.3 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Challenges
8.4 Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Bruton’s Tyrosine Kinase (BTK) Inhibitor Average Price (US$/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Product Type & Application
    Table 12. Global Key Manufacturers of Bruton’s Tyrosine Kinase (BTK) Inhibitor, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bruton’s Tyrosine Kinase (BTK) Inhibitor as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2018-2023) & (K Units)
    Table 18. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region (2018-2023)
    Table 19. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2024-2029) & (K Units)
    Table 20. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region (2024-2029)
    Table 21. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Region (2018-2023)
    Table 23. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Region (2024-2029)
    Table 25. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2018-2023) & (K Units)
    Table 27. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2024-2029) & (K Units)
    Table 28. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) by Type (2018-2023)
    Table 51. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) by Type (2024-2029)
    Table 52. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2018-2023)
    Table 53. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Type (2024-2029)
    Table 54. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Type (2018-2023)
    Table 57. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Type (2024-2029)
    Table 58. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Type (2018-2023)
    Table 59. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Type (2024-2029)
    Table 60. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) by Application (2018-2023)
    Table 61. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units) by Application (2024-2029)
    Table 62. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2018-2023)
    Table 63. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Application (2024-2029)
    Table 64. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Application (2018-2023)
    Table 67. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Application (2024-2029)
    Table 68. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Application (2018-2023)
    Table 69. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Application (2024-2029)
    Table 70. AbbVie Corporation Information
    Table 71. AbbVie Description and Business Overview
    Table 72. AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 73. AbbVie Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
    Table 74. AbbVie Recent Developments/Updates
    Table 75. Johnson & Johnson Corporation Information
    Table 76. Johnson & Johnson Description and Business Overview
    Table 77. Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 78. Johnson & Johnson Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
    Table 79. Johnson & Johnson Recent Developments/Updates
    Table 80. Principia Biopharma Corporation Information
    Table 81. Principia Biopharma Description and Business Overview
    Table 82. Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 83. Principia Biopharma Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
    Table 84. Principia Biopharma Recent Developments/Updates
    Table 85. Merck Corporation Information
    Table 86. Merck Description and Business Overview
    Table 87. Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 88. Merck Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
    Table 89. Merck Recent Developments/Updates
    Table 90. Sunesis Pharmaceuticals Corporation Information
    Table 91. Sunesis Pharmaceuticals Description and Business Overview
    Table 92. Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 93. Sunesis Pharmaceuticals Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
    Table 94. Sunesis Pharmaceuticals Recent Developments/Updates
    Table 95. BeiGene Corporation Information
    Table 96. BeiGene Description and Business Overview
    Table 97. BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 98. BeiGene Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
    Table 99. BeiGene Recent Developments/Updates
    Table 100. Novartis Corporation Information
    Table 101. Novartis Description and Business Overview
    Table 102. Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 103. Novartis Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
    Table 104. Novartis Recent Developments/Updates
    Table 105. Sanofi Corporation Information
    Table 106. Sanofi Description and Business Overview
    Table 107. Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 108. Sanofi Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
    Table 109. Sanofi Recent Developments/Updates
    Table 110. Celgene Corporation Corporation Information
    Table 111. Celgene Corporation Description and Business Overview
    Table 112. Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 113. Celgene Corporation Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
    Table 114. Celgene Corporation Recent Developments/Updates
    Table 115. Loxo Corporation Information
    Table 116. Loxo Description and Business Overview
    Table 117. Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 118. Loxo Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
    Table 119. Loxo Recent Developments/Updates
    Table 120. ArQule Corporation Information
    Table 121. ArQule Description and Business Overview
    Table 122. ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 123. ArQule Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
    Table 124. ArQule Recent Developments/Updates
    Table 125. Hengrui Corporation Information
    Table 126. Hengrui Description and Business Overview
    Table 127. Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 128. Hengrui Bruton’s Tyrosine Kinase (BTK) Inhibitor Product
    Table 129. Hengrui Recent Developments/Updates
    Table 130. Key Raw Materials Lists
    Table 131. Raw Materials Key Suppliers Lists
    Table 132. Bruton’s Tyrosine Kinase (BTK) Inhibitor Distributors List
    Table 133. Bruton’s Tyrosine Kinase (BTK) Inhibitor Customers List
    Table 134. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Trends
    Table 135. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Drivers
    Table 136. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Challenges
    Table 137. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Bruton’s Tyrosine Kinase (BTK) Inhibitor
    Figure 2. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Share by Type in 2022 & 2029
    Figure 4. Acalabrutinib Product Picture
    Figure 5. Zanubrutinib Product Picture
    Figure 6. Ibrutinib Product Picture
    Figure 7. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Share by Application in 2022 & 2029
    Figure 9. Tumor
    Figure 10. Autoimmunity
    Figure 11. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 12. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size (2018-2029) & (US$ Million)
    Figure 13. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales (2018-2029) & (K Units)
    Figure 14. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Average Price (US$/Unit) & (2018-2029)
    Figure 15. Bruton’s Tyrosine Kinase (BTK) Inhibitor Report Years Considered
    Figure 16. Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Share by Manufacturers in 2022
    Figure 17. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Share by Manufacturers in 2022
    Figure 18. The Global 5 and 10 Largest Bruton’s Tyrosine Kinase (BTK) Inhibitor Players: Market Share by Revenue in 2022
    Figure 19. Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 20. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 21. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2018-2029)
    Figure 22. North America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2018-2029)
    Figure 23. U.S. Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 24. Canada Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 25. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2018-2029)
    Figure 26. Europe Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2018-2029)
    Figure 27. Germany Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. France Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 29. U.K. Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. Italy Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. Russia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Region (2018-2029)
    Figure 33. Asia Pacific Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Region (2018-2029)
    Figure 34. China Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Japan Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 36. South Korea Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. India Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Australia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Taiwan Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Indonesia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Thailand Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Malaysia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Philippines Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2018-2029)
    Figure 45. Latin America Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2018-2029)
    Figure 46. Mexico Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Brazil Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Argentina Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Sales Market Share by Country (2018-2029)
    Figure 50. Middle East & Africa Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Market Share by Country (2018-2029)
    Figure 51. Turkey Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Saudi Arabia Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 53. UAE Bruton’s Tyrosine Kinase (BTK) Inhibitor Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Global Sales Market Share of Bruton’s Tyrosine Kinase (BTK) Inhibitor by Type (2018-2029)
    Figure 55. Global Revenue Market Share of Bruton’s Tyrosine Kinase (BTK) Inhibitor by Type (2018-2029)
    Figure 56. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Type (2018-2029)
    Figure 57. Global Sales Market Share of Bruton’s Tyrosine Kinase (BTK) Inhibitor by Application (2018-2029)
    Figure 58. Global Revenue Market Share of Bruton’s Tyrosine Kinase (BTK) Inhibitor by Application (2018-2029)
    Figure 59. Global Bruton’s Tyrosine Kinase (BTK) Inhibitor Price (US$/Unit) by Application (2018-2029)
    Figure 60. Bruton’s Tyrosine Kinase (BTK) Inhibitor Value Chain
    Figure 61. Bruton’s Tyrosine Kinase (BTK) Inhibitor Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Anti-Anxiety Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23Q7423
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Real-Time Thermal Cyclers Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-39X13417
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Actarit Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-3Q7887
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Bepotastine Besilate Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-14X7647
Fri Feb 23 00:00:00 UTC 2024

Add to Cart